An increased expression of EPHs (EPHB1, EPHB2, EPHB3, and EPHB4) and their ephrin ligands (ephrin-B1 and ephrin-B2) has been implicated in promoting angiogenesis and tumor progression in rhabdomyosarcoma [121,122,123,124]. Here, EPHB3 is linked to rhabdomyosarcoma.